<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ophthalmology</journal-id><journal-title-group><journal-title xml:lang="ru">Офтальмология</journal-title><trans-title-group xml:lang="en"><trans-title>Ophthalmology in Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1816-5095</issn><issn pub-type="epub">2500-0845</issn><publisher><publisher-name>Ophthalmology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18008/1816-5095-2023-1-120-127</article-id><article-id custom-type="elpub" pub-id-type="custom">ophthalmology-2050</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ И ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL &amp; EXPERIMENTAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Применение квантовых точек InP/ZnSe/ZnS в лечении экспериментального антибиотикорезистентного эндофтальмита in vivo</article-title><trans-title-group xml:lang="en"><trans-title>Application of InP/ZnSe/ZnS Quantum Dots in the Treatment of Experimental Antibiotic-Resistant Endophthalmitis in vivo</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2353-9610</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пономарев</surname><given-names>В. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Ponomarev</surname><given-names>V. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пономарев Вячеслав Олегович - кандидат медицинских наук, врач‑офтальмохирург,  заместитель генерального директора по научно‑клинической работе </p><p> ул. Академика Бардина, 4а, Екатеринбург, 620149, Российская Федерация </p></bio><bio xml:lang="en"><p>Ponomarev Vyacheslav O. - PhD, ophthalmosurgeon, deputy general director for scientific and clinical work </p><p> Academician Bardin str., 4A, Yekaterinburg, 620149, Russian Federation </p></bio><email xlink:type="simple">ponomarev-mntk@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9569-5906</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Казайкин</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kazaykin</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Казайкин Виктор Николаевич - доктор медицинских наук, врач‑офтальмохирург, ведущий научный сотрудник </p><p> ул. Академика Бардина, 4а, Екатеринбург, 620149, Российская Федерация </p></bio><bio xml:lang="en"><p>Kazaykin Viktor N. - MD, ophthalmic surgeon, leading researcher </p><p> Academician Bardin str., 4A, Yekaterinburg, 620149, Russian Federation </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8593-9364</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ткаченко</surname><given-names>К. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tkachenko</surname><given-names>K. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ткаченко Константин Андреевич - врач‑офтальмолог</p><p> ул. Академика Бардина, 4а, Екатеринбург, 620149, Российская Федерация </p></bio><bio xml:lang="en"><p>Tkachenko Konstantin A. -ophthalmologist </p><p> Academician Bardin str., 4A, Yekaterinburg, 620149, Russian Federation </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2529-3770</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вохминцев</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Vokhmintsev</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вохминцев Александр Сергеевич - Кандидат физико‑математических наук, Доцент </p><p> ул. Мира, 32, Екатеринбург, 620078, Российская Федерация </p></bio><bio xml:lang="en"><p>Vokhmintsev Alexander S. - PhD (Phys.‑Math.), Associate Professor </p><p> Mira str., 19, Yekaterinburg, 620002, Russian Federation </p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5573-7128</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вайнштейн</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Weinstein</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вайнштейн Илья Александрович - Доктор физико‑математических наук, профессор, главный  научный сотрудник</p><p> ул. Мира, 32, Екатеринбург, 620078, Российская Федерация </p></bio><bio xml:lang="en"><p>Weinstein Ilya A. - MD (Phys.‑Math.), Professor, chief researcher </p><p> Mira str., 19, Yekaterinburg, 620002, Russian Federation </p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4725-3681</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жданов</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhdanov</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алексей Евгеньевич Жданов - инженер‑исследователь</p><p> ул. Мира, 32, Екатеринбург, 620078, Российская Федерация </p></bio><bio xml:lang="en"><p>Zhdanov Alexey E. - research engineer </p><p> Mira str., 19, Yekaterinburg, 620002, Russian Federation </p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>АО «Екатеринбургский центр МНТК “Микрохирургия глаза”» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Eye Microsurgery Ekaterinburg Center</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Уральский федеральный университет имени первого Президента России Б.Н. Ельцина»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ural Federal University named after the First President of Russia B. N. Yeltsin</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>05</day><month>04</month><year>2023</year></pub-date><volume>20</volume><issue>1</issue><fpage>120</fpage><lpage>127</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пономарев В.О., Казайкин В.Н., Ткаченко К.А., Вохминцев А.С., Вайнштейн И.А., Жданов А.Е., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Пономарев В.О., Казайкин В.Н., Ткаченко К.А., Вохминцев А.С., Вайнштейн И.А., Жданов А.Е.</copyright-holder><copyright-holder xml:lang="en">Ponomarev V.O., Kazaykin V.N., Tkachenko K.A., Vokhmintsev A.S., Weinstein I.A., Zhdanov A.E.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.ophthalmojournal.com/opht/article/view/2050">https://www.ophthalmojournal.com/opht/article/view/2050</self-uri><abstract><p>Цель работы — моделирование экспериментального антибиотикорезистентного эндофтальмита на лабораторных животных с описанием механизмов взаимодействия квантовых точек (КТ) с инфекционным агентом.</p><sec><title>Материалы и методы</title><p>Материалы и методы. Объект исследования — лабораторные новозеландские кролики (2 особи мужского пола, возраст 4 месяца, вес 3,5 кг). Индуктор воспаления — культура внутрибольничного штамма метициллин-резистентного золотистого стафилококка (МРЗС), нечувствительного к гликопептидам. Первому кролику было выполнено интравитреальное введение конъюгата на основе 1 мг/0,05 мл ванкомицина в сочетании с 0,5 мкг 0,01 %/0,05 мл водным раствором квантовых точек InP/ZnSe/ZnS 660. Второму кролику выполнено интравитреальное введение 1 мг/0,1 мл ванкомицина. Динамическое наблюдение за течением клинического процесса производилось ежедневно посредством фоторегистрации переднего отрезка и ультразвуковой сонографии.</p></sec><sec><title>Результаты</title><p>Результаты. Конъюгат на основе 1 мг/0,05 мл ванкомицина в сочетании с 0,5 мкг 0,01 %/0,05 мл водного раствора квантовых точек InP/ZnSe/ZnS 660 продемонстрировал высокую антиинфекционную активность в отношении ванкомицин-резистентного МРЗС в данной группе исследования. Методом электронной микроскопии показано, что воздействие названного раствора на МРЗС описывается одномоментной способностью квантовых точек к тропности в отношении биологических объектов. Спектрофотометрическим методом обнаружена генерация супероксидных радикалов O2–• в водном растворе КТ при воздействии синего света.</p></sec><sec><title>Заключение</title><p>Заключение. Конъюгаты на основе квантовых точек можно рассматривать как одно из перспективных направлений лечения антибиотикорезистентных эндофтальмитов.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Purpose</title><p>Purpose: modeling of experimental antibiotic-resistant endophthalmitis on laboratory animals model describing the interaction of quantum dots and a biological organism and its physicochemical and kinetic aspects.</p></sec><sec><title>Material and methods</title><p>Material and methods. The object of the study is laboratory New Zealand rabbits (2 male, age 4 months, weight 3.5 kg). The inflammation inductor is the culture of Methicillin-Resistant Staphylococcus Aureus (MRSA). 1 mg/0.05 ml of vancomycin in combination with 0.5 μg (0.01 %)/0.05 ml by a solution of quantum dots InP/ZnSe/ZnS 660 was intravitreally administrated to the first rabbit. 1 mg/0.1 ml of vancomycin was intravitreally administrated to the second rabbit. Dynamic observation of the clinical process was performed daily by photo registration of the front segment and ultrasonic sonography.</p></sec><sec><title>Results</title><p>Results. The conjugate based on 1 mg/0.05 ml vancomycin coupled with 0.5 μg (0.01 %)/0.05 ml quantum dots InP/ZnSe/ZnS 660 demonstrated high anti-infectious activity against vancomycin-resistant MRSA. It was shown that the effect of the above solution on MRSA is described by the one-time ability of quantum dots by using electron microscopy. The presence of superoxide radicals O2–• generation in an aqueous solution of quantum dots under the action of blue light has also been proven by spectrophotometric method.</p></sec><sec><title>Conclusion</title><p>Conclusion. Conjugates based on quantum dots can be considered as one of the promising directions of treatment of antibiotic-resistant endophthalmitis.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>бактериальный эндофтальмит</kwd><kwd>конъюгаты</kwd><kwd>квантовые точки</kwd><kwd>антибиотикорезистентность</kwd><kwd>антиинфекционная активность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>bacterial endophthalmitis</kwd><kwd>conjugates</kwd><kwd>quantum dots</kwd><kwd>antibiotic resistance</kwd><kwd>anti-infective activity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Tabatabaei S.A., Aminzade S., Ahmadraji A., Kasaee A., Cheraqpour K. Early and complete vitrectomy versus tap and inject in acute post cataract surgery endophthalmitis presenting with hand motion vision; a quasi experimental study. BMC Ophthalmology. 2022;22(1):16. DOI: 10.1186/s12886-022-02247-8</mixed-citation><mixed-citation xml:lang="en">Tabatabaei S.A., Aminzade S., Ahmadraji A., Kasaee A., Cheraqpour K. Early and complete vitrectomy versus tap and inject in acute post cataract surgery endophthalmitis presenting with hand motion vision; a quasi experimental study. BMC Ophthalmology. 2022;22(1):16. DOI: 10.1186/s12886-022-02247-8</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Taban M., Behrens A., Newcomb R.L., Nobe M.Y., Saedi G., Sweet P.M., McDonnell P.J. Acute endophthalmitis following cataract surgery: A systematic review of the literature. Archives of Ophthalmology. 2005;123(5):613–620. DOI: 10.1001/ar-chopht.123.5.613</mixed-citation><mixed-citation xml:lang="en">Taban M., Behrens A., Newcomb R.L., Nobe M.Y., Saedi G., Sweet P.M., McDonnell P.J. Acute endophthalmitis following cataract surgery: A systematic review of the literature. Archives of Ophthalmology. 2005;123(5):613–620. DOI: 10.1001/ar-chopht.123.5.613</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Results of the Endophthalmitis Vitrectomy Study: A Randomized Trial of Immediate Vitrectomy and of Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis. Archives of Ophthalmology. 1995;113(12):1479–1496. DOI: 10.1001/archopht.1995.01100120009001</mixed-citation><mixed-citation xml:lang="en">Results of the Endophthalmitis Vitrectomy Study: A Randomized Trial of Immediate Vitrectomy and of Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis. Archives of Ophthalmology. 1995;113(12):1479–1496. DOI: 10.1001/archopht.1995.01100120009001</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dib B., Morris R.E., Oltmanns M.H., Sapp M.R., Glover J.P., Kuhn F. Complete and early vitrectomy for endophthalmitis after cataract surgery: An alternative treatment paradigm. Clinical Ophthalmology.2020;14:1945–1954. DOI: 10.2147/OPTH.S253228</mixed-citation><mixed-citation xml:lang="en">Dib B., Morris R.E., Oltmanns M.H., Sapp M.R., Glover J.P., Kuhn F. Complete and early vitrectomy for endophthalmitis after cataract surgery: An alternative treatment paradigm. Clinical Ophthalmology.2020;14:1945–1954. DOI: 10.2147/OPTH.S253228</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Relhan N., Pathengay A., Schwartz S.G., Flynn H.W. Jr. Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis. Retina. 2017;37(5):811–818. DOI: 10.1097/IAE.0000000000001603</mixed-citation><mixed-citation xml:lang="en">Relhan N., Pathengay A., Schwartz S.G., Flynn H.W. Jr. Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis. Retina. 2017;37(5):811–818. DOI: 10.1097/IAE.0000000000001603</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Read A.F., Woods R.J. Antibiotic resistance management. Evol. Med. Public Health. 2014;14(1):147. DOI: 10.1093/emph/eou024</mixed-citation><mixed-citation xml:lang="en">Read A.F., Woods R.J. Antibiotic resistance management. Evol. Med. Public Health. 2014;14(1):147. DOI: 10.1093/emph/eou024</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bartlett J.G., Gilbert D.N., Spellberg B. Seven ways to preserve the miracle of antibiotics. Clin. Infect. Dis. 2013;56(10):1445–1450. DOI: 10.1093/cid/cit070</mixed-citation><mixed-citation xml:lang="en">Bartlett J.G., Gilbert D.N., Spellberg B. Seven ways to preserve the miracle of antibiotics. Clin. Infect. Dis. 2013;56(10):1445–1450. DOI: 10.1093/cid/cit070</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">No authors listed. The antibiotic alarm. Nature. 2013;495(7440):14. DOI: 10.1038/495141a</mixed-citation><mixed-citation xml:lang="en">No authors listed. The antibiotic alarm. Nature. 2013;495(7440):14. DOI: 10.1038/495141a</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Viswanathan V.K. Off label abuse of antibiotics by bacteria. Gut. Microbes. 2014;5(1):3–4. DOI: 10.4161/gmic.28027</mixed-citation><mixed-citation xml:lang="en">Viswanathan V.K. Off label abuse of antibiotics by bacteria. Gut. Microbes. 2014;5(1):3–4. DOI: 10.4161/gmic.28027</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Luyt C.E., Brechot N., Trouillet J.L., Chastre J. Antibiotic stewardship in the intensive care unit. Crit. Care. 2014;18(5):480. DOI: 10.1186/s13054-014-0480-6</mixed-citation><mixed-citation xml:lang="en">Luyt C.E., Brechot N., Trouillet J.L., Chastre J. Antibiotic stewardship in the intensive care unit. Crit. Care. 2014;18(5):480. DOI: 10.1186/s13054-014-0480-6</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Grzybowski A., Brona P., Kim S.J. Microbial flora and resistance in ophthalmology: a review. Graefes Arch. Clin. Exp. Ophthalmol. 2017;255(5):851–862. DOI: 10.1007/s00417-017-3608-y</mixed-citation><mixed-citation xml:lang="en">Grzybowski A., Brona P., Kim S.J. Microbial flora and resistance in ophthalmology: a review. Graefes Arch. Clin. Exp. Ophthalmol. 2017;255(5):851–862. DOI: 10.1007/s00417-017-3608-y</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Miller D. Update on the Epidemiology and Antibiotic Resistance of Ocular Infections. Middle East Afr. J. Ophthalmol. 2017;24(1):30–42. DOI: 10.4103/meajo.MEA-JO_276_16</mixed-citation><mixed-citation xml:lang="en">Miller D. Update on the Epidemiology and Antibiotic Resistance of Ocular Infections. Middle East Afr. J. Ophthalmol. 2017;24(1):30–42. DOI: 10.4103/meajo.MEA-JO_276_16</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Michael C.A., Dominey Howes D., Labbate M. The antibiotic resistance crisis: causes, consequences, and management. Front Public Health. 2014;2:145. DOI: 10.3389/fpubh.2014.00145</mixed-citation><mixed-citation xml:lang="en">Michael C.A., Dominey Howes D., Labbate M. The antibiotic resistance crisis: causes, consequences, and management. Front Public Health. 2014;2:145. DOI: 10.3389/fpubh.2014.00145</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">David M., Richards D.M., Endres R.G. The Mechanism of Phagocytosis: Two Stages of Engulfment. Biophys J. 2014 Oct 7;107(7):1542–1553. DOI: 10.1016/j.bpj.2014.07.070</mixed-citation><mixed-citation xml:lang="en">David M., Richards D.M., Endres R.G. The Mechanism of Phagocytosis: Two Stages of Engulfment. Biophys J. 2014 Oct 7;107(7):1542–1553. DOI: 10.1016/j.bpj.2014.07.070</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Courtney C.M., Goodman S.M., Nagy T.A., Levy M., Bhusal P., Madinger N.E. Potentiating antibiotics in drug resistant clinical isolates via stimuli activated superoxide generation. Sci. Adv. 2017;3(10):1–10. DOI: 10.1126/sciadv.170177</mixed-citation><mixed-citation xml:lang="en">Courtney C.M., Goodman S.M., Nagy T.A., Levy M., Bhusal P., Madinger N.E. Potentiating antibiotics in drug resistant clinical isolates via stimuli activated superoxide generation. Sci. Adv. 2017;3(10):1–10. DOI: 10.1126/sciadv.170177</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Courtney C.M., Goodman S.M., McDaniel J.A., Madinger N.E., Chatterjee A., Nagpal P. Photoexcited quantum dots for killing multidrug resistant bacteria. Nat. Mater. 2016;15:529–534. DOI: 10.1038/nmat4542</mixed-citation><mixed-citation xml:lang="en">Courtney C.M., Goodman S.M., McDaniel J.A., Madinger N.E., Chatterjee A., Nagpal P. Photoexcited quantum dots for killing multidrug resistant bacteria. Nat. Mater. 2016;15:529–534. DOI: 10.1038/nmat4542</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Cheeseman K.H., Slater T.F. An introduction to free radical biochemistry. Brit. Med. Bull. 1993;49:481–493. DOI: 10.1093/oxfordjournals.bmb.a072625</mixed-citation><mixed-citation xml:lang="en">Cheeseman K.H., Slater T.F. An introduction to free radical biochemistry. Brit. Med. Bull. 1993;49:481–493. DOI: 10.1093/oxfordjournals.bmb.a072625</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cross A.R., Jones O.T.G. Enzymic mechanisms of superoxide production. Biochem. biophys. acta. 1991;1057:281–298. DOI: 10.1016/s0005-2728(05)80140-9</mixed-citation><mixed-citation xml:lang="en">Cross A.R., Jones O.T.G. Enzymic mechanisms of superoxide production. Biochem. biophys. acta. 1991;1057:281–298. DOI: 10.1016/s0005-2728(05)80140-9</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sandhu S.K., Kaur G. Mitochondrial Electron Transport Chain Complexes in Aging Rat Brain and Lymphocytes. Biogerontol. 2003;4(1):19–29. DOI: 10.1023/a:1022473219044</mixed-citation><mixed-citation xml:lang="en">Sandhu S.K., Kaur G. Mitochondrial Electron Transport Chain Complexes in Aging Rat Brain and Lymphocytes. Biogerontol. 2003;4(1):19–29. DOI: 10.1023/a:1022473219044</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kinnula V.L., Soini Y., Kvist Makela K., Savolainen E.R., Koistinen P. Antioxidant defense mechanisms in human neutrophils. Antioxid. Redox Signal. 2002;4(1):27–34. DOI: 10.1089/152308602753625825</mixed-citation><mixed-citation xml:lang="en">Kinnula V.L., Soini Y., Kvist Makela K., Savolainen E.R., Koistinen P. Antioxidant defense mechanisms in human neutrophils. Antioxid. Redox Signal. 2002;4(1):27–34. DOI: 10.1089/152308602753625825</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Valko M., Leibfritz D., Moncol J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007;39:44–84. DOI: 10.1016/j.biocel.2006.07.001</mixed-citation><mixed-citation xml:lang="en">Valko M., Leibfritz D., Moncol J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007;39:44–84. DOI: 10.1016/j.biocel.2006.07.001</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Imlay J.A. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat. Rev. Microbiol. 2013;11:443–454. DOI: 10.1038/nrmicro3032</mixed-citation><mixed-citation xml:lang="en">Imlay J.A. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat. Rev. Microbiol. 2013;11:443–454. DOI: 10.1038/nrmicro3032</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Goodman M., Levy M., Fei Fei L. Designing Superoxide Generating Quantum Dots for Selective Light-Activated Nanotherapy. Front. Chem. 2018;46(6):1–12. DOI: 10.3389/fchem.2018.00046</mixed-citation><mixed-citation xml:lang="en">Goodman M., Levy M., Fei Fei L. Designing Superoxide Generating Quantum Dots for Selective Light-Activated Nanotherapy. Front. Chem. 2018;46(6):1–12. DOI: 10.3389/fchem.2018.00046</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Пономарев В.О., Казайкин В.Н., Лизунов А.В., Вохминцев А.С., Вайнштейн И.А., Дежуров С.В. Оценка офтальмотоксического воздействия квантовых точек и биоконъюгатов на их основе в аспекте перспектив лечения резистентных эндофтальмитов. Экспериментальное исследование. (1-й этап). Офтальмология. 2021;18(3):476–487. DOI: 10.18008/1816-5095-2021-3-476-487</mixed-citation><mixed-citation xml:lang="en">Ponomarev V.O., Kazaykin V.N., Lizunov A.V. , Vokhmintsev A.S., Vainshtein I.A., Dezhurov S.V. Evaluation of the ophthalmotoxic effect of quantum dots and bioconjugates based on them in terms of the prospects for the treatment of resistant endophthalmitis. Experimental research (stage 1). Ophthalmology in Russia = Oftal’mologiya. 2021;18(3):476–487 (In Russ.). DOI: 10.18008/1816-5095-2021-3-476-487</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Пономарев В.О., Казайкин В.Н., Лизунов А.В., Вохминцев А.С., Вайнштейн И.А., Дежуров С.В, Оценка офтальмотоксического воздействия квантовых точек InP/ZnSe/ZnS 660 и биоконъюгатов на их основе в аспекте перспектив лечения резистентных эндофтальмитов. Экспериментальное исследование. Часть 2 (1-й этап). Офтальмология. 2021;18(4):876–884. DOI: 10.18008/1816-5095-2021-4-876-884</mixed-citation><mixed-citation xml:lang="en">Ponomarev V.O., Kazaykin V.N., Lizunov A.V., Vokhmintsev A.S., Vainshtein I.A., Dezhurov S.V. Evaluation of the ophthalmotoxic effect of quantum dots and bioconjugates based on them in terms of the prospects for the treatment of resistant endophthalmitis. Experimental research. Part 2. (stage 1). Ophthalmology = Oftal’mologiya. 2021;18(4):876–884 (In Russ.). DOI: 10.18008/1816-5095-2021-4-876-884</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Yaghini E., Pirker K.F., Kay C.W.M., Seifalian A.M., Macrobert A.J. Quantification of reactive oxygen species generation by photoexcitation of PEGylated quantum dots. Small. 2014;10(24):5106–5115. DOI: 10.1002/smll.201401209</mixed-citation><mixed-citation xml:lang="en">Yaghini E., Pirker K.F., Kay C.W.M., Seifalian A.M., Macrobert A.J. Quantification of reactive oxygen species generation by photoexcitation of PEGylated quantum dots. Small. 2014;10(24):5106–5115. DOI: 10.1002/smll.201401209</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Healy V.L., Lessard I.A., Roper D.I., Knox J.R., Walsh C.T. Vancomycin resistance in enterococci: reprogramming of the d Ala–d Ala ligases in bacterial peptidoglycan biosynthesis. Chemestry and Biology. 2000;7(5):109–119. DOI: 10.1016/S1074-5521(00)00116-2</mixed-citation><mixed-citation xml:lang="en">Healy V.L., Lessard I.A., Roper D.I., Knox J.R., Walsh C.T. Vancomycin resistance in enterococci: reprogramming of the d Ala–d Ala ligases in bacterial peptidoglycan biosynthesis. Chemestry and Biology. 2000;7(5):109–119. DOI: 10.1016/S1074-5521(00)00116-2</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Пономарев В.О., Казайкин В.Н., Лизунов А.В., Вохминцев А.С., Вайнштейн И.А., Розанова С.М., Кырф М.В. Лабораторный анализ антиинфекционной активности квантовых точек и биоконъюгатов на их основе в аспекте перспектив лечения воспалительных заболеваний глаза. Экспериментальное исследование (часть 3). Офтальмология 2022;19(1):188–194. DOI: 10.18008/1816-5095-2022-1-188-194</mixed-citation><mixed-citation xml:lang="en">Ponomarev V.O., Kazaykin V.N., Lizunov A.V., Vokhmintsev A.S., Vainshtein I.A., Rozanova S.M., Kirf M.V. Laboratory analysis of the anti infectious activity of quantum dots and bioconjugates based on them in the aspect of the prospects for the treatment of inflammatory diseases of the eye. Experimental research (Part 3). Ophthalmology = Ophthalmology in Russia. 2022;19(1):188–194 (In Russ.). DOI: 10.18008/1816-5095-2022-1-188-194</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">McCollum C.R., Bertram J.R., Nagpal P., Chatterjee A. Photoactivated Indium Phosphide Quantum Dots Treat Multidrug Resistant Bacterial Abscesses In Vivo. ACS Appl Mater Interfaces. 2021 Jul 7;13(26):30404–30419. DOI: 10.1021/acsami.1c08306. Epub 2021 Jun 22.PMID: 34156817</mixed-citation><mixed-citation xml:lang="en">McCollum C.R., Bertram J.R., Nagpal P., Chatterjee A. Photoactivated Indium Phosphide Quantum Dots Treat Multidrug Resistant Bacterial Abscesses In Vivo. ACS Appl Mater Interfaces. 2021 Jul 7;13(26):30404–30419. DOI: 10.1021/acsami.1c08306. Epub 2021 Jun 22.PMID: 34156817</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">McCollum C.R., Levy M., Bertram J.R., Nagpal P., Chatterjee A. Photoexcited Quantum Dots as Efficacious and Nontoxic Antibiotics in an Animal Model. ACS Biomater Sci Eng. 2021 May 10;7(5):1863–1875. DOI: 10.1021/acsbiomaterials.0c01406</mixed-citation><mixed-citation xml:lang="en">McCollum C.R., Levy M., Bertram J.R., Nagpal P., Chatterjee A. Photoexcited Quantum Dots as Efficacious and Nontoxic Antibiotics in an Animal Model. ACS Biomater Sci Eng. 2021 May 10;7(5):1863–1875. DOI: 10.1021/acsbiomaterials.0c01406</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
